Insiders Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:20 2025-12-05 pm EST			5-day change	1st Jan Change
99.72 ^USD	-1.16%		-4.87%	+0.24%

Dec. 05	Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns	RE
Dec. 05	Global markets live: Netflix, Visa, Airbus, Ferrovial, Leonardo…

Insiders

Top Midday Stories: Merck to Acquire Cidara Therapeutics for $9.2 Billion; Walmart Names John Furner as CEO	Nov. 14	MT
Merck & Co. Insider Sold Shares Worth $616,395, According to a Recent SEC Filing	Nov. 12	MT
Merck & Co. Insider Sold Shares Worth $720,040, According to a Recent SEC Filing	Nov. 04	MT
Organon Appoints Joseph Morrissey as Interim CEO After Investigation Finds Possible Sales Practice Irregularities	Oct. 27	MT
PRESS DIGEST- Financial Times - September 17	Sep. 16	RE
Top Midday Stories: US June Advance Trade Gap Narrows; Novo Nordisk Q2 Earnings Miss Estimates, Names New CEO	Jul. 29	MT
Merck to Buy Verona Pharma for About $10B	Jul. 09	MT
US CDC's report shows no evidence linking thimerosal-containing vaccines and autism	Jun. 24	RE
PRESS DIGEST-Wall Street Journal - March 6	Mar. 06	RE
Merck & Co. Insider Sold Shares Worth $714,745, According to a Recent SEC Filing	Feb. 20	MT
Merck & Co. Insider Sold Shares Worth $512,057, According to a Recent SEC Filing	Feb. 13	MT
Edgewise Therapeutics Names Behrad Derakhshan as COO; Shares Fall	Jan. 22	MT
Merck: Emerson Electric CEO to join board	Nov. 22
Merck Adds Emerson Electric Chief Executive to its Board	Nov. 22	MT
Merck & Co., Inc. Appoints Surendralal L. Karsanbha to its Board of Directors, Effective January 1, 2025	Nov. 22	CI
Zentalis Pharmaceuticals Appoints Julie Eastland as CEO	Nov. 13	MT
Robert Davis, Merck CEO: Another obesity drug?	24-03-28	MT
Global markets live: Darktrace, Merck, Meta, Apple, Eli Lilly...	24-03-07
Merck & Co. Insider Sold Shares Worth $29,538,998, According to a Recent SEC Filing	24-02-15	MT
Merck & Co. Insider Sold Shares Worth $4,805,521, According to a Recent SEC Filing	24-02-15	MT
Merck & Co. Insider Sold Shares Worth $1,845,083, According to a Recent SEC Filing	24-02-12	MT
Merck & Co. Insider Sold Shares Worth $2,411,111, According to a Recent SEC Filing	24-02-05	MT
Merck & Co. Insider Sold Shares Worth $6,420,349, According to a Recent SEC Filing	24-02-02	MT
Stéphane Bancel, CEO of Moderna: Merck-Moderna vaccine reduces risk of skin cancer recurrence	23-12-14	MT
Good Energy says ZapMap expands into mainland Europe	23-12-13	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Merck to Buy Verona Pharma for About $10B

July 09, 2025 at 12:30 pm EDT